Skip to main content

Prescription Drug Price Transparency program

The Prescription Drug Price Transparency Act, enacted during the 2018 Legislative Session, established Oregon’s Drug Price Transparency program within the Department of Consumer and Business Services. The program is directed by the statute to:

  1. Increase transparency regarding prescription drug costs and prices from pharmaceutical manufacturers
  2. Gather information from health insurance companies on prescription drugs
  3. Provide consumers a way to notify the department on a prescription drug price increase

News and updates

  • The program is hosting a public hearing on prescription drug prices on Tuesday, Nov. 19 from 5:30-7:30 p.m. in Hearing Room 50 at the Oregon State Capitol. The public is invited to provide comments and questions via the questionnare. There will also be satellite locations for the public to attend in Astoria, Medford, and Pendleton. More information can be found on the Public hearings page.
  • Share your Rx drug price story

  • Information regarding reports the department has received is posted on the Data page. More data will become available as reports are reviewed and determined complete.

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how